Bob DeSutter is a managing director and Global Group Head of the Health Care Team and has 17 years of investment banking experience. Bob started the health care advisory practice in 1996 and has transaction experience on numerous buy-side/sell-side, friendly/hostile, strategic/financial buyer and public/private deals. Since 1998, he has advised life sciences clients on sale transactions to Abbott Labs, Astra, Biomet, Boston Scientific, Cardinal Health, Thermo Fisher, Medtronic, Johnson & Johnson, Pfizer, St. Jude, Covidien, Smith & Nephew, GE Medical and Novartis, among others. Bob has completed financing transactions involving public and private equity, convertible debt, subordinated debt and senior secured debt.
Bob is a graduate of the University of Minnesota and the University of Virginia’s Darden Graduate School of Business.